GPX4-IN-9 (Compound A16) is an inhibitor of glutathione peroxidase 4 (GPX4) that specifically targets GPX4, both in vitro and in vivo, to induce ferroptosis. It exhibits cytotoxic effects on pancreatic cancer cells and can be utilized for cancer research.